Related Experiment Videos

Cryptococcosis, epileptic seizures and encephalopathy in a HIV-infected patient

M Tolnay1, M Elzi, P Reusser

  • 1Institut für Pathologie, Medizinische Universitätsklinik A, Basel.

Praxis
|February 28, 1998
PubMed

Insights

A case of cryptococcus neoformans meningoencephalitis in an HIV-infected patient highlights diagnostic and treatment challenges. Despite initial recovery, the patient experienced a fatal relapse, underscoring the severity of this opportunistic infection.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Critical Care Medicine

Background:

  • Cryptococcus neoformans is an opportunistic fungal pathogen that can cause severe meningoencephalitis, particularly in immunocompromised individuals like those with HIV/AIDS.
  • Early diagnosis and appropriate antifungal therapy are crucial for managing cryptococcal infections, but treatment can be complex.

Observation:

  • A 32-year-old HIV-positive male presented with cryptococcal meningoencephalitis and septicemia, initially responding well to intravenous amphotericin B followed by oral fluconazole.
  • Despite initial improvement, the patient experienced two seizures and a sudden decline into a deep coma, leading to death.
  • Autopsy confirmed severe meningoencephalitis and pneumonia caused by Cryptococcus neoformans.

Findings:

  • The case illustrates a challenging clinical course of cryptococcal meningoencephalitis, including a potential relapse or complication leading to a fatal outcome.
  • The exact cause of the terminal encephalopathy remained undetermined despite extensive clinical evaluation.
  • Autopsy findings confirmed the extensive nature of the fungal infection affecting both the central nervous system and lungs.

Implications:

  • This case underscores the need for vigilant monitoring and potentially prolonged or adjusted treatment strategies for cryptococcal meningoencephalitis in HIV patients.
  • Further research into the mechanisms of relapse and refractory disease in cryptococcosis is warranted.
  • Optimal management protocols for cryptococcal meningoencephalitis in immunocompromised populations require ongoing refinement to improve patient outcomes.

Related Concept Videos